Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gibb

Showing results (251-260 of 419) with videos related to

Pageof 42
Sort By:
AIDS (London, England)|March 22, 2008
The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in ZambiaMáirín Ryan, Susan Griffin, Bona Chitah, et al.
American Journal of Epidemiology|August 29, 2015
The Impact of Different CD4 Cell-Count Monitoring and Switching Strategies on Mortality in HIV-Infected African Adults on Antiretroviral Therapy: An Application of Dynamic Marginal Structural ModelsDeborah Ford, James M Robins, Maya L Petersen, et al.
Antimicrobial Agents and Chemotherapy|June 30, 2010
Impact of cotrimoxazole on carriage and antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae in HIV-infected children in ZambiaDarlington M Mwenya, Bambos M Charalambous, Patrick P J Phillips, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2010
Strategies for nevirapine initiation in HIV-infected children taking pediatric fixed-dose combination "baby pills" in Zambia: a randomized controlled trialV Mulenga, A Cook, A S Walker, et al.
AIDS (London, England)|July 21, 2015
Single-dose nevirapine exposure does not affect response to antiretroviral therapy in HIV-infected African children aged below 3 yearsPhilippa Musoke, Alexander J Szubert, Victor Musiime, et al.
Retrovirology|May 17, 2011
The evolution of HIV-1 reverse transcriptase in route to acquisition of Q151M multi-drug resistance is complex and involves mutations in multiple domainsJean L Mbisa, Ravi K Gupta, Desire Kabamba, et al.
Journal of the International AIDS Society|March 29, 2020
The cost-effectiveness of prophylaxis strategies for individuals with advanced HIV starting treatment in AfricaSimon M Walker, Edward Cox, Paul Revill, et al.
Circulation|June 29, 2005
Early structural and functional changes of the vasculature in HIV-infected children: impact of disease and antiretroviral therapyMarietta Charakida, Ann E Donald, Hannah Green, et al.
Plos One|May 3, 2011
Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effectsJessica E Haberer, Adrian Cook, A Sarah Walker, et al.
The Lancet. HIV|November 29, 2015
Prevalence, incidence, and associated risk factors of tuberculosis in children with HIV living in the UK and Ireland (CHIPS): a cohort studyAnna Turkova, Elizabeth Chappell, Ali Judd, et al.
Pageof 42

Showing results (251-260 of 419) with videos related to

Sort By:
Pageof 42
AIDS (London, England)|March 22, 2008
The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in ZambiaMáirín Ryan, Susan Griffin, Bona Chitah, et al.
American Journal of Epidemiology|August 29, 2015
The Impact of Different CD4 Cell-Count Monitoring and Switching Strategies on Mortality in HIV-Infected African Adults on Antiretroviral Therapy: An Application of Dynamic Marginal Structural ModelsDeborah Ford, James M Robins, Maya L Petersen, et al.
Antimicrobial Agents and Chemotherapy|June 30, 2010
Impact of cotrimoxazole on carriage and antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae in HIV-infected children in ZambiaDarlington M Mwenya, Bambos M Charalambous, Patrick P J Phillips, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2010
Strategies for nevirapine initiation in HIV-infected children taking pediatric fixed-dose combination "baby pills" in Zambia: a randomized controlled trialV Mulenga, A Cook, A S Walker, et al.
AIDS (London, England)|July 21, 2015
Single-dose nevirapine exposure does not affect response to antiretroviral therapy in HIV-infected African children aged below 3 yearsPhilippa Musoke, Alexander J Szubert, Victor Musiime, et al.
Retrovirology|May 17, 2011
The evolution of HIV-1 reverse transcriptase in route to acquisition of Q151M multi-drug resistance is complex and involves mutations in multiple domainsJean L Mbisa, Ravi K Gupta, Desire Kabamba, et al.
Journal of the International AIDS Society|March 29, 2020
The cost-effectiveness of prophylaxis strategies for individuals with advanced HIV starting treatment in AfricaSimon M Walker, Edward Cox, Paul Revill, et al.
Circulation|June 29, 2005
Early structural and functional changes of the vasculature in HIV-infected children: impact of disease and antiretroviral therapyMarietta Charakida, Ann E Donald, Hannah Green, et al.
Plos One|May 3, 2011
Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effectsJessica E Haberer, Adrian Cook, A Sarah Walker, et al.
The Lancet. HIV|November 29, 2015
Prevalence, incidence, and associated risk factors of tuberculosis in children with HIV living in the UK and Ireland (CHIPS): a cohort studyAnna Turkova, Elizabeth Chappell, Ali Judd, et al.
Pageof 42